SCHEMBL14728261

SCHEMBL14728261

NC(=O)c1c2c(c(Cl)n3c1nc1ccccc13)C1CCC2C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.40
ALDH1A1 P00352 3/20 0.40
GAA P10253 2/20 0.40
PRF1 P14222 1/20 0.38
HSD17B10 Q99714 2/20 0.37
HPGD P15428 1/20 0.37
CASP1 P29466 1/20 0.37
PDE4B Q07343 1/20 0.37
PKMYT1 Q99640 2/20 0.36
OPRM1 P35372 2/20 0.35
OPRD1 P41143 2/20 0.35
OPRK1 P41145 2/20 0.35
OGFRL1 Q5TC84 2/20 0.35
WEE1 P30291 1/20 0.35
ACHE P22303 2/20 0.34
BCHE P06276 1/20 0.34
ADORA2A P29274 2/20 0.34
ADORA1 P30542 2/20 0.34
EPHB4 P54760 1/20 0.34
MAPT P10636 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14728662 0.80 PDE4B (0.43) KDM4EALDH1A1GAAHSD17B10HPGD
SCHEMBL14728664 0.78 PDE4B (0.41) KDM4EALDH1A1GAAPRF1HSD17B10
SCHEMBL14728265 0.76 NPSR1 (0.53) KDM4EALDH1A1GAAPRF1HPGD
SCHEMBL14728665 0.75 PDE4B (0.55) KDM4EALDH1A1GAAHSD17B10HPGD
SCHEMBL14716459 0.75 KDM4E (0.44) KDM4EALDH1A1GAAPRF1HSD17B10
SCHEMBL14716329 0.73 PDE4B (0.68) KDM4EALDH1A1GAAHSD17B10HPGD
SCHEMBL14716115 0.72 PDE4B (0.59) KDM4EALDH1A1GAAPRF1HSD17B10
SCHEMBL14728269 0.71 PDE4B (0.40) KDM4EALDH1A1GAAPRF1HSD17B10
SCHEMBL14728264 0.69 PDE4B (0.53) KDM4EALDH1A1GAAPRF1HSD17B10
SCHEMBL4567517 0.65 KDM4E (0.60) KDM4EALDH1A1GAAPRF1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8822688-B2 Imidazo[1,2-a]pyridine derivative ASTELLAS PHARMA INC. (JP) 2014-09-02 US disclosed
US-8822688-B2 Imidazo[1,2-a]pyridine derivative ASTELLAS PHARMA INC. (JP) 2014-09-02 US disclosed
US-20130053363-A1 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE ASTELLAS PHARMA INC. (JP) 2013-02-28 US disclosed
US-20130053363-A1 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE ASTELLAS PHARMA INC. (JP) 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130053363-A1 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE PDE4B, PDE4A, PDE4C KDM4E 586/4885ALDH1A1 1070/4885GAA 507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.